Anjoo Kamboj
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Anjoo Kamboj has a total of 67 co-authors. Here are the top co-authors by number of shared publications:
Hitesh Malhotra
PCTE College of Pharmacy, Ludiana, India
5 shared publications- Shabir Sidhu
IK Gujral Punjab Technical University, Kapurthala, India
5 shared publications Ajay Kumar Saluja
4 shared publicationsManisha Bhatti
3 shared publicationsPermender Rathee
3 shared publicationsAjayKumar Saluja
2 shared publications
Latest Publications
- Open Access
- 30 September 2026
- Published by Oriental Scientific Publishing Company in Biomedical and Pharmacology Journal
- Vol. 3 (19) , 2300-2315
Computational Design of Novel Pyridine derivative as Potent Inhibitors of Insulin Receptor (IR) as Potential Anti-cancer Agent
Modern cancer chemotherapy places a strong emphasis on developing target-based strategies rather than traditional ones due to advances in biochemistry, advanced exploitation of knowledge regarding genetics, genomes and successful research about various forms of human cancer. Protein tyrosine kinases (PTKs) are the most explored of the numerous targets that have been found, confirmed, and inhibited at various cancer hallmarks. Owing to their synthetic accessibility, favorable pharmacokinetic and pharmacodynamic optimization potential—including absorption, distribution, metabolism, excretion, and toxicity (ADMET) profiles—oral bioavailability, reduced off-target effects, and cost efficiency, small-molecule inhibitors of IGF-1R have emerged as prominent candidates in recent therapeutic research. The Insilco techniques are in use now-a days can affects the entire drug development process as identifying and discovering new potential drug is time and cost effective. Here, we are applying multiple Insilco techniques to examine IR inhibition activity. To find a powerful molecule, we employed the best pharmacophore and the structure-based pharmacophore as 3D queries. Following lead generation and optimisation using Structure-Based Drug Design (SBDD), 100 novel derivatives were created. Molecular docking experiments were then conducted to anticipate interactions and pinpoint structural characteristics. Drug-likeness and ADMET tests were also used to evaluate pharmacokinetics features. According to Swiss ADME and docking investigations, only the three L12, L50, and L6 exhibited the best performance and were selected for additional processing. They were also thought to be appropriate for high-grade IR inhibitors. Further, directional approach is also need in clinical trials and commercialization.
- 30 September 2026
- Published by Oriental Scientific Publishing Company in Biomedical and Pharmacology Journal
- Vol. 3 (19) , 2300-2315
Open AccessComputational Design of Novel Pyridine derivative as Potent Inhibitors of Insulin Receptor (IR) as Potential Anti-cancer Agent
Modern cancer chemotherapy places a strong emphasis on developing target-based strategies rather than traditional ones due to advances in biochemistry, advanced exploitation of knowledge regarding genetics, genomes and successful research about various forms of human cancer. Protein tyrosine kinases (PTKs) are the most explored of the numerous targets that have been found, confirmed, and inhibited at various cancer hallmarks. Owing to their synthetic accessibility, favorable pharmacokinetic and pharmacodynamic optimization potential—including absorption, distribution, metabolism, excretion, and toxicity (ADMET) profiles—oral bioavailability, reduced off-target effects, and cost efficiency, small-molecule inhibitors of IGF-1R have emerged as prominent candidates in recent therapeutic research. The Insilco techniques are in use now-a days can affects the entire drug development process as identifying and discovering new potential drug is time and cost effective. Here, we are applying multiple Insilco techniques to examine IR inhibition activity. To find a powerful molecule, we employed the best pharmacophore and the structure-based pharmacophore as 3D queries. Following lead generation and optimisation using Structure-Based Drug Design (SBDD), 100 novel derivatives were created. Molecular docking experiments were then conducted to anticipate interactions and pinpoint structural characteristics. Drug-likeness and ADMET tests were also used to evaluate pharmacokinetics features. According to Swiss ADME and docking investigations, only the three L12, L50, and L6 exhibited the best performance and were selected for additional processing. They were also thought to be appropriate for high-grade IR inhibitors. Further, directional approach is also need in clinical trials and commercialization.
- 28 September 2026
- Published by Springer Nature in Journal of Pharmaceutical Innovation
- Vol. 22 (1) , 201
Computational Screening of Ziziphus Nummularia-Derived Phytochemicals: Molecular Docking & ADME Analysis For Rheumatoid Arthritis Therapy
- 28 September 2026
- Published by Springer Nature in Journal of Pharmaceutical Innovation
- Vol. 22 (1) , 201
Computational Screening of Ziziphus Nummularia-Derived Phytochemicals: Molecular Docking & ADME Analysis For Rheumatoid Arthritis Therapy
- 11 November 2025
- Published by Springer Nature in Inflammopharmacology
- Vol. 33 (12) , 7427-7443
Evaluation of the oxidative stress reduction and anti-inflammatory efficacy of fractions of the methanolic extract of the leaf part of Ziziphus nummularia using complete Freund’s adjuvant-induced arthritis in rats
Introduction Rheumatoid arthritis is a systemic immune-mediated disease characterized by persistent joint inflammation of multiple small and large joints mainly the joints of hands, feet, and knees. Medicinal plants remain a promising source for developing new anti-arthritic medications. This research evaluated the antioxidant and potential anti-arthritic effects of various fractions of methanolic extracts of Z. nummularia. Materials Evaluation was carried out using DPPH and the egg albumin denaturation method, followed by in vivo evaluation in a CFA-induced arthritis model in experimental rats. Results The DPPH assay showed maximum % inhibition by the chloroform fraction of the methanolic extract of Z. nummularia with an IC50 of 153.16 µg/ml. In vitro anti-arthritic studies determined that the chloroform fraction was the most active, showing the greatest inhibition of protein denaturation. This fraction was further analyzed for in vivo study at three dose levels in the CFA-induced arthritis model: AFLD (100 mg/kg), AFID (200 mg/kg), and AFHD (400 mg/kg). Discussion Inflammatory macrophage and granulocyte migration was attenuated by the active fraction in a dose-dependent manner, alleviating the anemia commonly associated with arthritis. Histopathological and microscopic examinations of joint sections revealed that the diclofenac, 200 mg/kg AFID, and 400 mg/kg AFHD groups exhibited reduced necrosis and edema. Radiographic images of the hind paws showed that the high-dose active fraction significantly suppressed joint inflammation and slowed disease progression compared to diclofenac (standard). Conclusion Overall, the findings suggest that Z. nummularia represents a prospective source of natural therapeutics with antioxidant and anti-inflammatory properties, offering promising therapeutic effects for relieving various ailments related to inflammatory responses.
- 11 November 2025
- Published by Springer Nature in Inflammopharmacology
- Vol. 33 (12) , 7427-7443
Evaluation of the oxidative stress reduction and anti-inflammatory efficacy of fractions of the methanolic extract of the leaf part of Ziziphus nummularia using complete Freund’s adjuvant-induced arthritis in rats
Introduction Rheumatoid arthritis is a systemic immune-mediated disease characterized by persistent joint inflammation of multiple small and large joints mainly the joints of hands, feet, and knees. Medicinal plants remain a promising source for developing new anti-arthritic medications. This research evaluated the antioxidant and potential anti-arthritic effects of various fractions of methanolic extracts of Z. nummularia. Materials Evaluation was carried out using DPPH and the egg albumin denaturation method, followed by in vivo evaluation in a CFA-induced arthritis model in experimental rats. Results The DPPH assay showed maximum % inhibition by the chloroform fraction of the methanolic extract of Z. nummularia with an IC50 of 153.16 µg/ml. In vitro anti-arthritic studies determined that the chloroform fraction was the most active, showing the greatest inhibition of protein denaturation. This fraction was further analyzed for in vivo study at three dose levels in the CFA-induced arthritis model: AFLD (100 mg/kg), AFID (200 mg/kg), and AFHD (400 mg/kg). Discussion Inflammatory macrophage and granulocyte migration was attenuated by the active fraction in a dose-dependent manner, alleviating the anemia commonly associated with arthritis. Histopathological and microscopic examinations of joint sections revealed that the diclofenac, 200 mg/kg AFID, and 400 mg/kg AFHD groups exhibited reduced necrosis and edema. Radiographic images of the hind paws showed that the high-dose active fraction significantly suppressed joint inflammation and slowed disease progression compared to diclofenac (standard). Conclusion Overall, the findings suggest that Z. nummularia represents a prospective source of natural therapeutics with antioxidant and anti-inflammatory properties, offering promising therapeutic effects for relieving various ailments related to inflammatory responses.
- 1 November 2025
- Published by Bentham Science Publishers Ltd. in Current Materials Science
- Vol. 18 (6) , 758-776
Potential Biomolecule Fisetin: Molecular and Pharmacological Perspectives
The naturally occurring, bioactive dietary flavonoid known as fisetin, also known as a tetrahydroxy flavone, is widely present in foods like apples, strawberries, grapes, persimmons, onions, kiwi, kale, and others. In addition, due to their increased safety, affordability, and practicality for oral administration, dietary flavonoids are the focus of intense research. The configuration, quantity, and kind of hydroxyl groups it contains in relation to functional groups in the nuclear structure determine its bioavailability, metabolism, and biological activity. Fisetin exerts its wide range of pharmacological activities by modulating various pathways, making it useful for diverse biological conditions. These pathways include PI-3 kinase/AKT/p38, TFEB and Nrf2, suppression of EGF-induced MMP-9 & sp-1 transcription, AKT/MAPK, JAKSTAT/ NF-kB, MEK/ERK, COX-2/iNOS, NF-kB/p300/IKK, VEGFR1/p-ERK1/2/ p38/pJNK, NF-κB/I-κBα, COX-2/WNT/EGFR/NF-κB, CDKN1B/P70S6K, PI3K/ AKT/CREB, PI3K/AKT/GSK3β, TLR4/NF-κB, and TXNIP/MAPKs, contributing to apoptotic cell death and potential therapeutic applications, making it a valuable molecule in various health contexts. Pleiotropic pharmacological properties of the polyphenol fisetin, make the molecule effective as antihyperalgesic, antileishmanial, antiinflammatory, antidiabetic, antihypertensive & cardioprotective, anti-photo inflammatory, antiproliferative, anti-cancer drug and used in psoriasis, ACD, AMD, SCI, hair growth promoter, SLE, AOM, SS2 infections, UL, PVR, Huntington’s, Alzheimer’s diseases. This study explores the flavone molecule fisetin and its structural, chemical, biological, pharmacological, and molecular properties.
- 1 November 2025
- Published by Bentham Science Publishers Ltd. in Current Materials Science
- Vol. 18 (6) , 758-776
Potential Biomolecule Fisetin: Molecular and Pharmacological Perspectives
The naturally occurring, bioactive dietary flavonoid known as fisetin, also known as a tetrahydroxy flavone, is widely present in foods like apples, strawberries, grapes, persimmons, onions, kiwi, kale, and others. In addition, due to their increased safety, affordability, and practicality for oral administration, dietary flavonoids are the focus of intense research. The configuration, quantity, and kind of hydroxyl groups it contains in relation to functional groups in the nuclear structure determine its bioavailability, metabolism, and biological activity. Fisetin exerts its wide range of pharmacological activities by modulating various pathways, making it useful for diverse biological conditions. These pathways include PI-3 kinase/AKT/p38, TFEB and Nrf2, suppression of EGF-induced MMP-9 & sp-1 transcription, AKT/MAPK, JAKSTAT/ NF-kB, MEK/ERK, COX-2/iNOS, NF-kB/p300/IKK, VEGFR1/p-ERK1/2/ p38/pJNK, NF-κB/I-κBα, COX-2/WNT/EGFR/NF-κB, CDKN1B/P70S6K, PI3K/ AKT/CREB, PI3K/AKT/GSK3β, TLR4/NF-κB, and TXNIP/MAPKs, contributing to apoptotic cell death and potential therapeutic applications, making it a valuable molecule in various health contexts. Pleiotropic pharmacological properties of the polyphenol fisetin, make the molecule effective as antihyperalgesic, antileishmanial, antiinflammatory, antidiabetic, antihypertensive & cardioprotective, anti-photo inflammatory, antiproliferative, anti-cancer drug and used in psoriasis, ACD, AMD, SCI, hair growth promoter, SLE, AOM, SS2 infections, UL, PVR, Huntington’s, Alzheimer’s diseases. This study explores the flavone molecule fisetin and its structural, chemical, biological, pharmacological, and molecular properties.
- 13 November 2024
- Published by Taylor & Francis in Journal of Asian Natural Products Research
- Vol. 27 (4) , 591-614
Evaluation of the potential anti-arthritic effects and evaluation of acute oral toxicity of the active fraction of Eclipta prostrata leaves in rat model
The primary goal of this research was to isolate and assess the bioactive compounds within Eclipta prostrata Linn's chloroform extract, with a focus on their potential to combat arthritis, validating its traditional use. Initially, antioxidant characteristics were evaluated, followed by fractionation through column chromatography. The in-vivo safety assessment, following OECD TG 425 Guidelines, showed no mortality at doses up to 2000 mg/kg, confirming the fraction's safety. Subsequently, the active fraction was assessed in a complete Freund's adjuvant-induced arthritis model. It demonstrated a dose-dependent inhibitory effect on inflammation and improved various parameters, including thermal latency time, dorsal flexion, motility, and motor coordination. Active bio constituents like rutin, stigmasterol, quercetin, and beta-sitosterol were estimated in the active fraction. The findings provide validation for the traditional use of E. prostrata as a potential plant with anti-arthritic properties, suggesting its potential suitability for rheumatoid arthritis treatment.
- 13 November 2024
- Published by Taylor & Francis in Journal of Asian Natural Products Research
- Vol. 27 (4) , 591-614
Evaluation of the potential anti-arthritic effects and evaluation of acute oral toxicity of the active fraction of Eclipta prostrata leaves in rat model
The primary goal of this research was to isolate and assess the bioactive compounds within Eclipta prostrata Linn's chloroform extract, with a focus on their potential to combat arthritis, validating its traditional use. Initially, antioxidant characteristics were evaluated, followed by fractionation through column chromatography. The in-vivo safety assessment, following OECD TG 425 Guidelines, showed no mortality at doses up to 2000 mg/kg, confirming the fraction's safety. Subsequently, the active fraction was assessed in a complete Freund's adjuvant-induced arthritis model. It demonstrated a dose-dependent inhibitory effect on inflammation and improved various parameters, including thermal latency time, dorsal flexion, motility, and motor coordination. Active bio constituents like rutin, stigmasterol, quercetin, and beta-sitosterol were estimated in the active fraction. The findings provide validation for the traditional use of E. prostrata as a potential plant with anti-arthritic properties, suggesting its potential suitability for rheumatoid arthritis treatment.
- Open Access
- 31 December 2023
- Published by Oriental Scientific Publishing Company in Biomedical and Pharmacology Journal
- Vol. 16 (4) , 2283-2291
Simultaneous Estimation of Curcumin and Gentamicin by UV-VIS Spectrometric Methods or Derivative Spectroscopic Techniques
A simultaneous study is very important analytical parameter which helps to assess compatibility of mixture of drugs. UV spectrophotometer is one of the simplest and efficient methods to assess simultaneous parameters. Due to its economical approach, we have used UV spectrophotometer. Curcumin and Gentamicin sulphate have zero crossing points of 420 nm and 244 nm, respectively, in first-order derivative spectroscopy. The solvent for the spectrophotometric process was 0.1 N NaOH. Curcumin and Gentamicin sulphate linearity was established over range of concentrations of 2–12 g/ml, with correlation coefficients of 0.995 and 0.993. The mean percent recoveries Curcumin and Gentamicin sulphate were found to be in the range of 98.88 percent and 98.54 percent, respectively. The approach has been found to be repeatable in both inter day and intraday testing. The approach was proven to be both precise and reliable. According to the recovery investigation, the approach was effectively applied to pharmaceutical formulation with no interference from excipients. The results of the analysis were statistically evaluated, as well as by recovery trials. The LOD and LOQ for Gentamicin sulphate in phosphate buffer were found to be 0.024µg/ml and 0.045µg/ml, respectively and values for Curcumin were 0.024µg/ml and 0.037 µg/ml, respectively which indicates adequate sensitivity of method
- 31 December 2023
- Published by Oriental Scientific Publishing Company in Biomedical and Pharmacology Journal
- Vol. 16 (4) , 2283-2291
Open AccessSimultaneous Estimation of Curcumin and Gentamicin by UV-VIS Spectrometric Methods or Derivative Spectroscopic Techniques
A simultaneous study is very important analytical parameter which helps to assess compatibility of mixture of drugs. UV spectrophotometer is one of the simplest and efficient methods to assess simultaneous parameters. Due to its economical approach, we have used UV spectrophotometer. Curcumin and Gentamicin sulphate have zero crossing points of 420 nm and 244 nm, respectively, in first-order derivative spectroscopy. The solvent for the spectrophotometric process was 0.1 N NaOH. Curcumin and Gentamicin sulphate linearity was established over range of concentrations of 2–12 g/ml, with correlation coefficients of 0.995 and 0.993. The mean percent recoveries Curcumin and Gentamicin sulphate were found to be in the range of 98.88 percent and 98.54 percent, respectively. The approach has been found to be repeatable in both inter day and intraday testing. The approach was proven to be both precise and reliable. According to the recovery investigation, the approach was effectively applied to pharmaceutical formulation with no interference from excipients. The results of the analysis were statistically evaluated, as well as by recovery trials. The LOD and LOQ for Gentamicin sulphate in phosphate buffer were found to be 0.024µg/ml and 0.045µg/ml, respectively and values for Curcumin were 0.024µg/ml and 0.037 µg/ml, respectively which indicates adequate sensitivity of method
- 31 July 2021
- Published by Springer Nature
- p. 583-608
Medicinal Plant Based Advanced Drug Delivery System for the Treatment of Chronic Lung Diseases
- 31 July 2021
- Published by Springer Nature
- p. 583-608
Medicinal Plant Based Advanced Drug Delivery System for the Treatment of Chronic Lung Diseases
- 4 June 2021
- Published by Sciencedomain International in Journal of Pharmaceutical Research International
- Vol. 33 (30B) , 97-111
Protective Role of Fisetin in STZ Induced Diabetic Nephropathy in Rats
Objectives: Chronic diabetes mellitus associated with devastating complication the diabetic nephropathy, that further progress to ESRD,a major cause of morbidity and premature mortality in many countries worldwide. Accumulated evidences demonstrated that long standing hyperglycemia induced oxidative stress, inflammatory cytokines, and fibrosis plays a significant role in DN. Fisetin, a bioflavonoid, exhibited variety of promising pharmacological properties such as, anti-diabetic, antioxidant, anti-inflammatory, anti-hyperlipidemic ,and anti-carcinogenics. Hence, the present study was hypothesized to investigate, the effect of fisetin on streptozotocin-induced diabetic nephropathy in rats. Materials and Methods: Sprague Dawley rats were divided into 6 groups (n=6) as normal control, diabetic control (vehicle), Glimepiride (0.5 mg/kg, orally) and Fisetin treatment (2.5, 5 and 10 mg/kg, orally) groups. After the confirmation of diabetes, vehicle/drug treatments were started and continued for 6 weeks. Serum glucose, body weight, were measured on weekly basis.Thereafter, on the last day of treatment protocol, ie 42 day, serum insulin, HbA1c in blood, lipid parameters, creatinine, albumin and urea in serum and in urine creatinine excretion, albumin were measured along with urine volume and creatinine clearance. In addition, weight of kidney and histopathological studies were carried out. Results: Fisetin treatment significantly attenuated reduction in body weight. Also, it significantly decreased the blood glucose level, ameliorate lipid profile and HbA1c (pConclusions: The results indicated that fisetin ameliorated diabetic nephropathy through its antidiabetic and antioxidant effect which may be attributed to inhibition of downward pathway of glycemia induced oxidative stress, inflammation and necroptosis of renal tissue.
- 4 June 2021
- Published by Sciencedomain International in Journal of Pharmaceutical Research International
- Vol. 33 (30B) , 97-111
Protective Role of Fisetin in STZ Induced Diabetic Nephropathy in Rats
Objectives: Chronic diabetes mellitus associated with devastating complication the diabetic nephropathy, that further progress to ESRD,a major cause of morbidity and premature mortality in many countries worldwide. Accumulated evidences demonstrated that long standing hyperglycemia induced oxidative stress, inflammatory cytokines, and fibrosis plays a significant role in DN. Fisetin, a bioflavonoid, exhibited variety of promising pharmacological properties such as, anti-diabetic, antioxidant, anti-inflammatory, anti-hyperlipidemic ,and anti-carcinogenics. Hence, the present study was hypothesized to investigate, the effect of fisetin on streptozotocin-induced diabetic nephropathy in rats. Materials and Methods: Sprague Dawley rats were divided into 6 groups (n=6) as normal control, diabetic control (vehicle), Glimepiride (0.5 mg/kg, orally) and Fisetin treatment (2.5, 5 and 10 mg/kg, orally) groups. After the confirmation of diabetes, vehicle/drug treatments were started and continued for 6 weeks. Serum glucose, body weight, were measured on weekly basis.Thereafter, on the last day of treatment protocol, ie 42 day, serum insulin, HbA1c in blood, lipid parameters, creatinine, albumin and urea in serum and in urine creatinine excretion, albumin were measured along with urine volume and creatinine clearance. In addition, weight of kidney and histopathological studies were carried out. Results: Fisetin treatment significantly attenuated reduction in body weight. Also, it significantly decreased the blood glucose level, ameliorate lipid profile and HbA1c (pConclusions: The results indicated that fisetin ameliorated diabetic nephropathy through its antidiabetic and antioxidant effect which may be attributed to inhibition of downward pathway of glycemia induced oxidative stress, inflammation and necroptosis of renal tissue.
- 3 April 2021
- Published by Springer Nature in Journal of Diabetes & Metabolic Disorders
- Vol. 20 (1) , 571-582
Nephroprotective effect of Vanillic acid in STZ-induced diabetic rats
Purpose To investigate the protective effect of vanillic acid (VA) in streptozotocin (STZ)-induced diabetic nephropathy (DN) in rats. Methods Experimental diabetes mellitus in rats was induced by intraperitoneally administration of single dose of STZ (55 mg/kg). The animals were divided into 5 groups viz., normal control, diabetic control, glimepiride (0.5 mg/kg, orally) and VA treatment (50 and 100 mg/kg, orally) groups. The treatment was started after the confirmation of hyperglycemia (> 250 mg/dl) and continued for 6 weeks. Serum glucose level, and body weight were measured weekly. At the end of study, HbA1c in whole blood, insulin, lipid profile, urea, creatinine and albumin in serum. Creatinine and albumin were measured in urine along with creatinine clearance. In addition, kidney weight and histopathology were assessed. Results Treatment with VA markedly attenuated STZ-induced body weight loss and hyperglycemia, along with improved lipid profile and HbA1c, without significant alteration of serum insulin levels. It also decreased urea, creatinine and increased albumin in serum. Moreover, VA, significantly reduced urine volume, urinary albumin along with marked improvement in creatinine clearance. Further, the VA treatment significantly reverse the raised levels of oxidative stress markers, pro-inflammatory and fibrotic markers viz. TNF-α, IL-1β, IL-6, TGF-β1 and NFκB activity in kidney tissue. These effects are associated with amelioration of histopathological alterations compared to diabetic control rats. While glimepiride produced similar antihyperglycemic effect but the effect on albuminuria, oxidative stress markers and cytokine levels were less significant as compared to VA (100 mg/kg). Conclusions In conclusion, VA exhibited nephroprotective effect through amelioration of kidney dysfunction and damage in diabetic rats. The observed nephroprotective effect of VA may be ascribed to inhibition of hyperglycemia induced oxido-inflammatory stress and necroptosis of renal tissue possibly due to its antihyperglycemic, antioxidant and anti-inflammatory actions.
- 3 April 2021
- Published by Springer Nature in Journal of Diabetes & Metabolic Disorders
- Vol. 20 (1) , 571-582
Nephroprotective effect of Vanillic acid in STZ-induced diabetic rats
Purpose To investigate the protective effect of vanillic acid (VA) in streptozotocin (STZ)-induced diabetic nephropathy (DN) in rats. Methods Experimental diabetes mellitus in rats was induced by intraperitoneally administration of single dose of STZ (55 mg/kg). The animals were divided into 5 groups viz., normal control, diabetic control, glimepiride (0.5 mg/kg, orally) and VA treatment (50 and 100 mg/kg, orally) groups. The treatment was started after the confirmation of hyperglycemia (> 250 mg/dl) and continued for 6 weeks. Serum glucose level, and body weight were measured weekly. At the end of study, HbA1c in whole blood, insulin, lipid profile, urea, creatinine and albumin in serum. Creatinine and albumin were measured in urine along with creatinine clearance. In addition, kidney weight and histopathology were assessed. Results Treatment with VA markedly attenuated STZ-induced body weight loss and hyperglycemia, along with improved lipid profile and HbA1c, without significant alteration of serum insulin levels. It also decreased urea, creatinine and increased albumin in serum. Moreover, VA, significantly reduced urine volume, urinary albumin along with marked improvement in creatinine clearance. Further, the VA treatment significantly reverse the raised levels of oxidative stress markers, pro-inflammatory and fibrotic markers viz. TNF-α, IL-1β, IL-6, TGF-β1 and NFκB activity in kidney tissue. These effects are associated with amelioration of histopathological alterations compared to diabetic control rats. While glimepiride produced similar antihyperglycemic effect but the effect on albuminuria, oxidative stress markers and cytokine levels were less significant as compared to VA (100 mg/kg). Conclusions In conclusion, VA exhibited nephroprotective effect through amelioration of kidney dysfunction and damage in diabetic rats. The observed nephroprotective effect of VA may be ascribed to inhibition of hyperglycemia induced oxido-inflammatory stress and necroptosis of renal tissue possibly due to its antihyperglycemic, antioxidant and anti-inflammatory actions.
- 1 February 2021
- Published by Galenos Yayinevi in Turkish Journal of Pharmaceutical Sciences
- Vol. 18 (1) , 104-110
Protective Effect of Dalbergia sissoo Extract Against Amyloid-β (1-42)-induced Memory Impairment, Oxidative Stress, and Neuroinflammation in Rats
Objectives: The ayurvedic literature reports that Dalbergia sissoo, a common medicinal plant for gastric and skin problems, has brain-revitalizing effects. However, the neuroprotective effect of this herb on an amyloid-beta (A beta) 1-42 model of Alzheimer's disease (AD) is yet unknown. The current study describes the protective effect of ethanolic extracts of D. sissoo leaves (EEDS) against A beta (1-42)-induced cognitive deficit, oxidative stress, and neuroinflammation in rats. Materials and Methods: EEDS (300 and 500 mg/kg) was orally administered to rats for 2 weeks prior to intracerebroventricular A beta (1-42) treatment. The neuroprotective effect of EEDS was assessed by evaluating behavioral, biochemical, and neuroinflammatory parameters in the rat hippocampus. Memory function was assessed via the Morris water maze (MWM) task 2 weeks after A beta (1-42) administration. After 3 weeks, surgery was performed, all biochemical parameters were evaluated, and histopathological examination of the tissues was carried out. Results: EEDS improved the cognitive ability of A beta (1-42)-administered rats in the MWM task. It reduced oxidative stress by significantly decreasing nitrite and malondialdehyde levels and increasing catalase activity and glutathione levels in the rat brain. Moreover, EEDS mitigated neuroinflammation in rats by decreasing the concentration of neuroinflammatory markers in a dose-dependent manner. Conclusion: D. sissoo leaf extract has a beneficial role in alleviating cognitive deficits in AD by modulating cholinergic function, oxidative stress, and neuroinflammation.
- 1 February 2021
- Published by Galenos Yayinevi in Turkish Journal of Pharmaceutical Sciences
- Vol. 18 (1) , 104-110
Protective Effect of Dalbergia sissoo Extract Against Amyloid-β (1-42)-induced Memory Impairment, Oxidative Stress, and Neuroinflammation in Rats
Objectives: The ayurvedic literature reports that Dalbergia sissoo, a common medicinal plant for gastric and skin problems, has brain-revitalizing effects. However, the neuroprotective effect of this herb on an amyloid-beta (A beta) 1-42 model of Alzheimer's disease (AD) is yet unknown. The current study describes the protective effect of ethanolic extracts of D. sissoo leaves (EEDS) against A beta (1-42)-induced cognitive deficit, oxidative stress, and neuroinflammation in rats. Materials and Methods: EEDS (300 and 500 mg/kg) was orally administered to rats for 2 weeks prior to intracerebroventricular A beta (1-42) treatment. The neuroprotective effect of EEDS was assessed by evaluating behavioral, biochemical, and neuroinflammatory parameters in the rat hippocampus. Memory function was assessed via the Morris water maze (MWM) task 2 weeks after A beta (1-42) administration. After 3 weeks, surgery was performed, all biochemical parameters were evaluated, and histopathological examination of the tissues was carried out. Results: EEDS improved the cognitive ability of A beta (1-42)-administered rats in the MWM task. It reduced oxidative stress by significantly decreasing nitrite and malondialdehyde levels and increasing catalase activity and glutathione levels in the rat brain. Moreover, EEDS mitigated neuroinflammation in rats by decreasing the concentration of neuroinflammatory markers in a dose-dependent manner. Conclusion: D. sissoo leaf extract has a beneficial role in alleviating cognitive deficits in AD by modulating cholinergic function, oxidative stress, and neuroinflammation.